| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $202K | -86.2% |
| Cost of Revenue | $778K | -94.9% |
| Gross Profit | -$576K | +95.8% |
| R&D Expense | $16.4M | -37.4% |
| SG&A Expense | $18.3M | -27.4% |
| Operating Income | -$35.8M | +59.2% |
| Pre-tax Income | -$35.5M | +59.3% |
| Income Tax | -$2K | -103.5% |
| Net Income | -$35.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.3M | -39.4% |
| Accounts Receivable | $11K | -91.6% |
| Inventory | $176K | -69.8% |
| Current Assets | $25.2M | -36.7% |
| Total Assets | $27.1M | -50.1% |
| Current Liabilities | $11.3M | +12.8% |
| Total Liabilities | $12.0M | -52.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.6M | +47.5% |
| Capital Expenditures | $486K | -75.1% |
| Investing Cash Flow | $7.7M | -86.0% |
| Financing Cash Flow | $10.1M | +248.9% |
| Free Cash Flow | -$27.1M | +48.5% |
| +59.3% |
| EPS (Basic) | -$4.89 | +67.3% |
| Stockholders' Equity |
| $15.1M |
| -47.9% |